50 related articles for article (PubMed ID: 8229954)
1. Effects of medroxyprogesterone acetate or gonadotrophin-releasing hormone agonist on suppression of spermatogenesis in the dog (Canis familiaris).
Paramo RM; Renton JP; Ferguson JM; Concannon PW
J Reprod Fertil Suppl; 1993; 47():387-97. PubMed ID: 8229954
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of the gonadotoxicity of Cytoxan in the dog by adjuvant treatment with a luteinizing hormone-releasing hormone agonist.
Goodpasture JC; Bergstrom K; Vickery BH
Cancer Res; 1988 Apr; 48(8):2174-8. PubMed ID: 2964898
[TBL] [Abstract][Full Text] [Related]
3. Effect of progestogens and androgens upon spermatogenesis and steroidogenesis in dogs.
England GC
J Reprod Fertil Suppl; 1997; 51():123-38. PubMed ID: 9404279
[TBL] [Abstract][Full Text] [Related]
4. Protection of spermatogenesis in rats from the cytotoxic procarbazine by the depot formulation of Zoladex, a gonadotropin-releasing hormone agonist.
Ward JA; Robinson J; Furr BJ; Shalet SM; Morris ID
Cancer Res; 1990 Feb; 50(3):568-74. PubMed ID: 2137024
[TBL] [Abstract][Full Text] [Related]
5. Reversible downregulation of endocrine and germinative testicular function (hormonal castration) in the dog with the GnRH-agonist azagly-nafarelin as a removable implant "Gonazon"; a preclinical trial.
Ludwig C; Desmoulins PO; Driancourt MA; Goericke-Pesch S; Hoffmann B
Theriogenology; 2009 Apr; 71(7):1037-45. PubMed ID: 19233456
[TBL] [Abstract][Full Text] [Related]
6. Recrudescence of spermatogenesis in the dog following downregulation using a slow release GnRH agonist implant.
Goericke-Pesch S; Spang A; Schulz M; Ozalp G; Bergmann M; Ludwig C; Hoffmann B
Reprod Domest Anim; 2009 Jul; 44 Suppl 2():302-8. PubMed ID: 19754591
[TBL] [Abstract][Full Text] [Related]
7. Effects of an LHRH agonist analog upon sexual function in male dogs. Suppression, reversibility, and effect of testosterone replacement.
Vickery BH; McRae GI; Briones W; Worden A; Seidenberg R; Schanbacher BD; Falvo R
J Androl; 1984; 5(1):28-42. PubMed ID: 6231277
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptive therapy for polycystic ovary disease after chronic gonadotropin-releasing agonist administration. Predictors of continued ovarian suppression.
Elkind-Hirsch KE; Anania C; Malinak R
J Reprod Med; 1996 Sep; 41(9):645-52. PubMed ID: 8887188
[TBL] [Abstract][Full Text] [Related]
9. Response to gonadotrophin-releasing hormone by the intact male dog: serum testosterone, luteinizing hormone and follicle-stimulating hormone.
Purswell BJ; Wilcke JR
J Reprod Fertil Suppl; 1993; 47():335-41. PubMed ID: 8229946
[TBL] [Abstract][Full Text] [Related]
10. Gonadotropin releasing hormone (GnRH) agonists in male contraception.
Swerdloff RS; Steiner BS; Bhasin S
Med Biol; 1986; 63(5-6):218-24. PubMed ID: 2939304
[TBL] [Abstract][Full Text] [Related]
11. Arsenic trioxide impairs spermatogenesis via reducing gene expression levels in testosterone synthesis pathway.
Chiou TJ; Chu ST; Tzeng WF; Huang YC; Liao CJ
Chem Res Toxicol; 2008 Aug; 21(8):1562-9. PubMed ID: 18630931
[TBL] [Abstract][Full Text] [Related]
12. Protection by steroid contraceptives against procarbazine-induced sterility and genotoxicity in male rats.
Velez de la Calle JF; Jégou B
Cancer Res; 1990 Feb; 50(4):1308-15. PubMed ID: 2137028
[TBL] [Abstract][Full Text] [Related]
13. Suppression of growth hormone does not affect ongoing spermatogenesis in rats.
Awoniyi CA; Veeramachaneni DN; Roberts D; Tucker KE; Chandrashekar V; Schlaff WD
J Androl; 1999; 20(1):102-8. PubMed ID: 10100480
[TBL] [Abstract][Full Text] [Related]
14. The effects of continuous treatment of stallions with high levels of a potent GnRH analogue.
Boyle MS; Skidmore J; Zhang J; Cox JE
J Reprod Fertil Suppl; 1991; 44():169-82. PubMed ID: 1795259
[TBL] [Abstract][Full Text] [Related]
15. Adenohypophyseal function in bitches treated with medroxyprogesterone acetate.
Beijerink NJ; Bhatti SF; Okkens AC; Dieleman SJ; Mol JA; Duchateau L; Van Ham LM; Kooistra HS
Domest Anim Endocrinol; 2007 Feb; 32(2):63-78. PubMed ID: 16455223
[TBL] [Abstract][Full Text] [Related]
16. [Effect of injection of testosterone undecanoate and depot medroxyprogesterone acetate on the suppression of spermatogenesis].
Tang W; Gu Y; Tong J; Ma D; Wang X; Yuan D; Chen Z; Bremner WJ
Zhonghua Nan Ke Xue; 2004 Aug; 10(8):572-7, 581. PubMed ID: 15362516
[TBL] [Abstract][Full Text] [Related]
17. [Effect of MPA and MPA + TU on the rat spermatogenesis and sexual hormones].
Jia Y; Cui YG; Wang XH; Tong JS; Ma DZ; Cai RF; Di FS; Sha JH
Zhonghua Nan Ke Xue; 2002; 8(2):109-11. PubMed ID: 12479022
[TBL] [Abstract][Full Text] [Related]
18. Effects of chronic gonadotropin-releasing hormone agonist treatment on serum luteinizing hormone and testosterone concentrations in boars.
Almond GW; Esbenshade KL; Smith CA; Richards RG
Am J Vet Res; 1992 Jan; 53(1):22-5. PubMed ID: 1531744
[TBL] [Abstract][Full Text] [Related]
19. Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.
Pogach LM; Lee Y; Gould S; Giglio W; Huang HF
Cancer Res; 1988 Aug; 48(15):4354-60. PubMed ID: 3134124
[TBL] [Abstract][Full Text] [Related]
20. Reversibility of androgen deprivation therapy in patients with prostate cancer.
Fridmans A; Chertin B; Koulikov D; Lindenberg T; Gelber H; Leiter C; Farkas A; Spitz IM
J Urol; 2005 Mar; 173(3):784-9. PubMed ID: 15711270
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
